• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

LimFlow

Catheter-based innovations we can’t stop thinking about

December 21, 2023 By Danielle Kirsh

Catheter-based devices had their year in 2023. Medtech companies set their sights on improving patient care in cardiology, neurology and more. Our previous roundup of the top 10 most-read catheter-based news stories of 2023 wasn't enough for us. Medical Tubing + Extrusion's editors could not stop thinking about several other stories when … [Read more...] about Catheter-based innovations we can’t stop thinking about

Filed Under: Catheters Tagged With: Endolumik, LimFlow, medtronic, ReCor Medical, synchron

Inari Medical plans to buy LimFlow Medical for up to $415M

November 1, 2023 By Jim Hammerand

LimFlow system treating chronic limb-threatening ischemia

Inari Medical today announced a definitive agreement to purchase LimFlow Medical for up to $415 million. The deal comes just weeks after Paris-based LimFlow won FDA premarket approval (PMA) for its breakthrough system to treat chronic limb-threatening ischemia (CLTI). San Jose, California–based Inari said it expects to complete the … [Read more...] about Inari Medical plans to buy LimFlow Medical for up to $415M

Filed Under: Catheters, Stents Tagged With: Inari Medical, LimFlow

How LimFlow’s foot-saving system prevents amputations in patients with no other options

September 22, 2023 By Jim Hammerand

An illustration of the LimFlow System for Transcatheter Arterialization of Deep Veins, specifically the crossing stent that routes blood from the artery to the vein.

LimFlow’s breakthrough system for treating chronic limb-threatening ischemia (CLTI) is the first of its kind approved by the FDA for this severe form of peripheral artery disease (PAD). For CLTI patients who have lost blood flow below their knee and have no other suitable endovascular or surgical treatment options available, the LimFlow System … [Read more...] about How LimFlow’s foot-saving system prevents amputations in patients with no other options

Filed Under: Catheters, Metals, Needles, Stents, Uncategorized Tagged With: LimFlow

FDA approves LimFlow chronic limb-threatening ischemia treatment

September 12, 2023 By Sean Whooley

LimFlow system treating chronic limb-threatening ischemia

LimFlow announced today that the FDA approved its LimFlow System for treating chronic limb-threatening ischemia (CLTI). Approval enables the treatment to help those with CLTI with no other suitable endovascular or surgical treatment options available. These patients can face major amputation as a result of their condition. France-based … [Read more...] about FDA approves LimFlow chronic limb-threatening ischemia treatment

Filed Under: Catheters Tagged With: fda, LimFlow

Study backs LimFlow system for treating chronic limb-threatening ischemia

March 31, 2023 By Sean Whooley

LimFlow system treating chronic limb-threatening ischemia

LimFlow announced that new study results demonstrated statistically significant survival with its chronic limb-threatening ischemia (CLTI) treatment. Paris-based LimFlow’s results came from its Promise II U.S. pivotal trial. They were published in today’s issue of the New England Journal of Medicine (NEJM). Data demonstrated 66% amputation-free … [Read more...] about Study backs LimFlow system for treating chronic limb-threatening ischemia

Filed Under: Catheters Tagged With: LimFlow

LimFlow raises $40M for chronic limb-threatening ischemia treatment

April 6, 2022 By Sean Whooley

LimFlow Logo

LimFlow announced that it closed an oversubscribed Series D financing round worth $40 million (€36 million). Paris-based LimFlow developed the LimFlow system for minimally invasive treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD). The system uses a family of transcatheter products designed … [Read more...] about LimFlow raises $40M for chronic limb-threatening ischemia treatment

Filed Under: Catheters Tagged With: LimFlow

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS